Press Releases

February 13th, 2023

2nd consecutive quarter of positive Adjusted EBITDA[1] 4% Adjusted EBITDA margin[2] places company in top 3 position for profitability amongst its peers[3] 9% growth in adult use revenue[4] over prior quarter; 5% growth in adult-use revenue[5] year over year 40% increase in medical net revenue[6] with $1.1 million record month revenue in November 2022 1st […]

February 7th, 2023

TORONTO, February 7, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) will now announce on Monday, February 13 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at […]

February 1st, 2023

TORONTO, February 1, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) will announce on February 8 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]

January 30th, 2023

TORONTO, January 30, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has signed a new European cannabis distribution partner, representing a one-year, approximately $1 million contract[1], significantly bolstering the Company’s record $1.2 million year-to-date sales in its growing international channel. “This new announcement […]

November 28th, 2022

Successful completion of TSX listing review Expansion of adult-use portfolio into key fifth province 5 provinces now selling Aleafia’s adult-use products TORONTO, November 28, 2022 – Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has completed the TSX delisting review […]

November 9th, 2022

Adjusted EBITDA[1] profitability achieved in Q2 FY2023, ahead of plan 21% increase in total revenue year over year to $14.5 23% increase in branded cannabis net revenue[2] year over year to $9.4 million #3 ranking in total retail sales pull through growth among 20 top Canadian LPs[3] #2 milled and #4 pre-roll market share ranking […]

November 2nd, 2022

TORONTO, November 2, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on November 9 prior to market open its fiscal year 2023 second quarter results for the period ending September 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]

November 1st, 2022

16 total new listings added to the Sunday Market portfolio by February 2023 9 new Divvy products in profitable flower, vape, and milled categories Kin Slips portfolio expands to include the California brand’s best-selling CBN product Shut Eye Plus CBD-forward brand Noon & Night extends giftable CBD product lineup Innovative Bogart’s Kitchen portfolio adds to […]

September 29th, 2022

TORONTO, September 29, 2022 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the results of the vote on the election of directors at its annual meeting of shareholders held on September 27, 2022 (the “Meeting”). All six nominees set out in the management information […]

September 16th, 2022

TORONTO, September 16, 2022 – Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) announces that the Toronto Stock Exchange (“TSX”) issued a decision today to extend its delisting review period until November 29, 2022.  The Company will provide further updates as warranted.   For Investor & […]

August 11th, 2022

31% increase in branded cannabis net revenue[1] to $10.0 million from $7.6 million in the prior year #12 ranking for market share in core markets[2] for Q1 FY2023 In the Ontario value category, Divvy has attained #5 market share in pre-roll and #7 in flower Secured new international partnership representing approximately $4.6 million sales commitment […]

August 4th, 2022

TORONTO, August 4, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on August 11 prior to market open its fiscal year 2023 first quarter results for the period ending June 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]

June 28th, 2022

TORONTO, June 28, 2022 — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced amendment of its unsecured convertible debentures (the “Debenture Amendments”).   “We are delighted we have now completed this transaction,” said Tricia Symmes Aleafia Health’s CEO.  “We want […]

June 28th, 2022

151% increase in branded cannabis net revenue[1] to $36.8 million in 15-month fiscal year 2022 ended March 31, 2022 (new fiscal year end) from $14.6 million in the prior 12-month year $8 million in branded cannabis net revenue for Q5, a growth of 55% calendar year over calendar year 3rd highest increase in overall market […]

June 24th, 2022

TORONTO, June 24, 2022 — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced private placement (the “Private Placement”) representing aggregate gross proceeds of approximately $5.6 million. Pursuant to the Private Placement, an aggregate of 68,151,515 units were issued at a […]